SYNAIRGEN RES LTD has a total of 11 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United Kingdom, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are PERIODONTIX INC, ASCENDIS PHARMA OPHTHALMOLOGY DIVISION AS and EVANS-FREKE STEPHEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 5 | |
#2 | China | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Hungary | 1 | |
#5 | Serbia | 1 | |
#6 | Slovenia | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Tear Victoria Jane | 5 |
#2 | Monk Phillip David | 5 |
#3 | Roberts James Jonathan Welch | 5 |
#4 | Puddicombe Sarah Margaret | 1 |
#5 | Foo Soo-Wei | 1 |
#6 | Davies Donna | 1 |
Publication | Filing date | Title |
---|---|---|
GB202014114D0 | Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid | |
GB202011284D0 | Use of inhaled interferon-beta to improve outcome in SARS-CoV-2 infected patients | |
GB202011216D0 | Use of inhaled interferon-beta to improve outcome in sars-cov-2 infected patients | |
CN102883741A | Therapy for influenza like illness | |
GB201008114D0 | Therapy for influenza like illness | |
GB201004144D0 | Therapy for influenza like illness | |
US2009004139A1 | Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |